Information de reference pour ce titreAccession Number: | 00000929-200407000-00005.
|
Author: | Mihalopoulos, Cathrine; Magnus, Anne; Carter, Rob; Vos, Theo
|
Institution: | Senior Research Fellow (Health Economics), Program Evaluation Unit, School of Population Health, University of Melbourne, Victoria 3010, Australia (Mihalopoulos) Associate Professor (Health Economics), Program Evaluation Unit, School of Population Health, University of Melbourne, Victoria 3010, Australia (Carter) Senior Project Officer, Health Surveillance and Evaluation Section, Rural and Regional Health and Aged Care Services, Department of Human Services, Melbourne, Australia (Magnus) Senior Epidemiologist and Associate Professor, Health Surveillance and Evaluation Section, Rural and Regional Health and Aged Care Services, Department of Human Services, Melbourne, Australia (Vos)
|
Title: | |
Source: | Australian and New Zealand Journal of Psychiatry. 38(7):511-519, July 2004.
|
Abstract: | Objective: Existing evidence suggests that family interventions can be effective in reducing relapse rates in schizophrenia and related conditions. Despite this, such interventions are not routinely delivered in Australian mental health services. The objective of the current study is to investigate the incremental cost-effectiveness ratios (ICERs) of introducing three types of family interventions, namely: behavioural family management (BFM); behavioural intervention for families (BIF); and multiple family groups (MFG) into current mental health services in Australia.
Method: The ICER of each of the family interventions is assessed from a health sector perspective, including the government, persons with schizophrenia and their families/carers using a standardized methodology. A two-stage approach is taken to the assessment of benefit. The first stage involves a quantitative analysis based on disability-adjusted life years (DALYs) averted. The second stage involves application of 'second filter' criteria (including equity, strength of evidence, feasibility and acceptability to stakeholders) to results. The robustness of results is tested using multivariate probabilistic sensitivity analysis.
Results: The most cost-effective intervention, in order of magnitude, is BIF (A$8000 per DALY averted), followed by MFG (A$21 000 per DALY averted) and lastly BFM (A$28 000 per DALY averted). The inclusion of time costs makes BFM more cost-effective than MFG. Variation of discount rate has no effect on conclusions.
Conclusions: All three interventions are considered 'value-for-money' within an Australian context. This conclusion needs to be tempered against the methodological challenge of converting clinical outcomes into a generic economic outcome measure (DALY). Issues surrounding the feasibility of routinely implementing such interventions need to be addressed.
Copyright (C) 2004 Blackwell Publishing Ltd.
|
Author Keywords: | behaviour therapy; cost-effectiveness; family therapy; schizophrenia.
|
References: | 1. Dixon LB, Lehman AF. Family interventions for schizophrenia. Schizophrenia Bulletin 1995; 21:631-643.
2. Lehman AF, Steinwachs DM. Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin 1998; 24:1-10.
3. Pharoah FM, Mari JJ, Streiner D. Family intervention for schizophrenia (Cochrane Review). In: The Cochrane Library, Issue 3 Oxford: Update Software, 2001.
4. Penn DL, Mueser KT. Research update on the psychosocial treatment of schizophrenia. American Journal of Psychiatry 1996; 153:607-617.
5. SANE Australia. National survey of services for carers of people with a mental illness, 1998 Melbourne: SANE Australia, 1998.
6. SANE Australia. SANE Mental Health Report 2002-03. Melbourne: SANE Australia, 2003.
7. Haby M, Carter R, Mihalopoulos C et al. Assessing cost-effectiveness - mental health. Introduction to the study and methods. Australian and New Zealand Journal of Psychiatry in press.
8. Falloon IR, Boyd JL, McGill CW et al. Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine 1982; 306:1437-1440.
9. McFarlane WR, Link B, Dushay R et al. Psychoeducational multiple family groups: four-year relapse outcome in schizophrenia. Family Process 1995; 34:127-144.
10. Tarrier N, Barrowclough C, Vaughn C et al. The community management of schizophrenia. A controlled trial of a behavioural intervention with families to reduce relapse. British Journal of Psychiatry 1988; 153:532-542.
11. Falloon IR, Boyd JL, McGill CW. Family care of schizophrenia. New York: Guilford, 1984.
12. Liberman RP, Cardin V, McGill CW et al. Behavioural family management of schizophrenia: clinical outcome and costs. Psychiatric Annals 1987; 17:610-619.
13. Jablensky A, McGrath J, Herrman H et al. People living with psychotic illness: an Australian study 1997-98. Canberra: Department of Health and Aged Care, 1999.
14. Randolph ET, Eth S, Glynn SM et al. Behavioural family management in schizophrenia. Outcome of a clinic-based intervention. British Journal of Psychiatry 1994; 164:501-506.
15. Magnus A, Carr V, Mihalopoulos C et al. Assessing cost-effectiveness of drug interventions for schizophrenia. Australian and New Zealand Journal of Psychiatry in press.
16. Gureje O, Herrman H, Harvey C et al. Defining disability in psychosis: performance of the diagnostic interview for psychosis-disability module (DIP-DIS) in the Australian National Survey of Psychotic Disorders. Australian and New Zealand Journal of Psychiatry 2001; 35:846-851.
17. Stouthard MEA, Essink-Bot M-L, Bonsel GJ et al. Disability weights for diseases in the Netherlands. Rotterdam: Department of Public Health, Erasmus University, 1997.
18. Jablensky A, Sartorius N, Ernberg G et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.[erratum appears in Psychol Medical Monogr Suppl. 1992 November; 22 (4): following 1092]. Psychological Medicine - Monograph Supplement 1992; 20:1-97.
19. Tarrier N, Barrowclough C, Porceddu K et al. The Salford Family Intervention Project: relapse rates of schizophrenia at five and eight years. British Journal of Psychiatry 1994; 165:829-832.
20. Tarrier N, Lowson K, Barrowclough C. Some aspects of family interventions in schizophrenia. II. Financial considerations. British Journal of Psychiatry 1991; 159:481-484.
21. Jacobs P, Fassbender K. The measurement of indirect costs in the health economics evaluation literature. A review. International Journal of Technology Assessment in Health Care 1998; 14:799-808.
22. Mihalopoulos C. ACE-MH family interventions for psychoses. Melbourne: Centre for Health Program Evaluation, 2003.
23. Gold MR, Siegel JE, Russel LB et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
24. Drummond MF, O'Brien B, Stoddart GL et al. Methods for the economic evaluation of health care programmes, 2nd edn. Oxford: Oxford Medical Publications, 1997.
|
Language: | English.
|
Document Type: | Schizophrenia and related psychoses.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0004-8674
|
NLM Journal Code: | 9i6, 0111052
|
Annotation(s) | |
|
|